Health-related quality of life in cancer patients treated with immune checkpoint inhibitors in randomised controlled trials: A systematic review and meta-analysis
Andrea Boutros(The University of Sydney), Francesco Spagnolo(Martin University), P. Pronzato(Accademia Nazionale dei Lincei), Elena Croce(Ospedale Policlinico San Martino), Marco Bruzzone(Ospedale Policlinico San Martino), Matteo Lambertini(Ospedale Policlinico San Martino), Marcello Ceppi(Ospedale Policlinico San Martino), Enrica T. Tanda(Ospedale Policlinico San Martino), Federica Cecchi(Ospedale Policlinico San Martino), Luca Arecco(Ospedale Policlinico San Martino)
Cited by 42
Related Papers
Cancer and fertility preservation: international recommendations from an expert meeting
|BMC Medicine|2016|779
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline
|Annals of Oncology|2022|271
The treatment of advanced melanoma: Current approaches and new challenges
|Critical Reviews in Oncology/Hematology|2024|140
Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy
|Seminars in Cancer Biology|2019|119